Ferroptosis 2023: New Insights & Discoveries

Raphael Rodriguez Dr. Raphael Rodriguez, Institut Curie, France, will chair a session entitled: "Ferroptosis 10 Years Later: What's Next?", on the 10th years anniversary of the ferroptosis discovery.

Dr. Rodriguez will join Redox Medicine 2023 on June 21-23 to present a talk entitled "Ferroptosis 2023: New Insights & Discoveries".

Join Redox Medicine 2023 to learn more about this session and benefit from Dr. Rodriguez's experience. You can submit a related abstract here.

Redox Medicine 2023 Congress
June 21-23, 2023 - Paris, France
Website | LinkedIn | Facebook

News

Raphaël Rodriguez won the Redox Medicine 2023 Best Scientific Achievement for his latest scientific discovery

Redox Meidicine 2023 Best Scientific Achievement Award Raphael Rodriguez, Institut Curie, France "Targeting Mitochondrial Copper: Therapeutic Stra...

Redox Medicine 2023 Best Short Oral Presentation on Mitochondria-Related Oxidative Stress in Diverticular Disease

Redox Meidicine 2023 Best Short Oral Presentation Award Martina Cappelletti, research fellow (BD) at the department of "Translation and Precis...

Redox Medicine 2023 Best Poster Presentation Award

Redox Meidicine 2023 Best Poster Presentation Award Talal Salti, Technion - Israel Institute of Technology, Israel "Induction of Hydrogen Sulfide ...

The Report Book of the Workshop "Oxidative Stress: From Antioxidants to Redox Medicine" is Now Available

You can now order the Redox Medicine Society (RMS) Workshop 2023 report book. This year's RMS workshop has been updated to cover: "Oxidative St...

Redox Medicine 2023 List of Posters

More than 61 communications were presented during Redox Medicine 2023 from major talks to short orals and poster. This year 20+ posters were sh...

Agilent shared their latest data at Redox Medicine 2023

Christophe Iochem, Cell Analysis Product Specialist at Agilent Technologies, France presented a short oral talk entitled “Mitochondrial ...

Antioxidant Capacity Biomarkers, A Path Forward To Develop ROS-Inducing Drugs For Cancer Therapy

Dr. Nikolas Gunkel, Deutsches Krebsforschungszentrum (DKFZ), Germany, will join Redox Medicine 2023 this June to present his interesting findings...

Arsenic-Copper: A Double-Edged Sword for a Unique Double Benefit against Immunological Disorders

Dr. Carole Nicco, President of the Redox Medicine Society, Institut Cochin - INSERM U1016, Université de Paris, France, will join Redox...

Friedreich's ataxia: the pathological iron-redox axis revisited

Dr. Benoit D'Autréaux, Paris-Saclay University, France, will join Redox Medicine 2023 this June to present his recent research on "Friedreic...

Targeting Mitochondrial Copper: Therapeutic Strategies

Dr. Raphael Rodriguez will talk about his outstanding findings during Redox Medicine 2023. In his breakthrough discovery, he uncovered a&n...

The Determination of Intracellular Labile Ironome for Diagnosis and Prognosis of Iron-Related Disorders: the Example of Friedreich’s Ataxia’

Dr. Charareh Pourzand, University of Bath, United Kingdom, will join Redox Medicine 2023 this June to present his recent research on "The Determi...

Effects of reactive sulfur species in macrophage activation and regulation of apoptosis/necrosis pathways in cancer cells

Dr. Moran Benhar from Technion university, Israel will join Redox Medicine 2023 on June 21-23 to present a talk entitled "Effects of reactive sulfur s...